Review




Structured Review

Biogenex mu392a uc
Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/mu392a+uc/pmc13083883-12-4-2
Average 86 stars, based on 1 article reviews
mu392a uc - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

other:

Article Title: Lineage Differentiation Markers as a Proxy for Embryo Viability in Farm Ungulates
Article Snippet: , , Bovine, ovine, porcine , Biogenex, MU392A-UC , ( , ) and own unpublished observations ( ) .

Article Title: Methods and systems for converting precursor cells into gastric tissues through directed differentiation
Article Snippet: Antibody Species Company Product No. Dilution alpha-SM-actin rabbit GeneTex GTX100034 1:200 aPKC rabbit Santa Cruz sc216 1:200 B-catenin rabbit Santa Cruz sc7199 1:100 Cdx2 mouse Biogenex MU392A-UC 1:500 ChrA rabbit Immunostar 20086 1:500 Desmin goat Santa Cruz sc7559 1:200 E-Cadherin mouse BD Biosciences 610182 1:500 E-Cadherin goat R&D Systems AF648 1:500 FoxF1 goat R&D Systems AF4798 1:500 Gastrin rabbit Dako A0568 1:1000 Gata4 mouse Santa Cruz sc25310 1:200 Ghrelin goat Santa Cruz sc10368 1:200 H. pylori rabbit Abcam ab80519 1:1000 Hnf1B mouse BD Biosciences 612504 1:500 Hnf1B goat Santa Cruz sc4711 1:500 Ki67 rabbit Abcam ab833 1:200 Ki67 rat Dako m7249 1:100 Klf5 rat Dr. Ryozo Nagai Shindo et al., 2002 1:2000 Muc5AC mouse Abcam ab3649 1:500 Nanog rabbit Abcam ab21624 1:500 Oct3/4 mouse Santa Cruz sc5279 1:500 Pdx1 goat Abcam ab47383 1:5000 pHH3 rabbit Cell Signaling 9701 1:500 Serotonin (5-HT) rabbit Immunostar 20080 1:1000 Somatostatin goat Santa Cruz sc7819 1:100 Sox2 goat Santa Cruz sc17320 1:500 Sox2 rabbit Seven Hills Bioreagents WRAB-1236 1:1000 Tff2 goat Santa Cruz sc23558 1:500 Vimentin goat Santa Cruz sc7557 1:200 TABLE 2 qPCR Primer Sequences.



Similar Products

86
Biogenex mu392a uc
Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/mu392a+uc/pmc13083883-12-4-2
Average 86 stars, based on 1 article reviews
mu392a uc - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc mu392a uc rrid ab 2923402 rabbit ant sox2
Mu392a Uc Rrid Ab 2923402 Rabbit Ant Sox2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/pm40924577-66-11-18
Average 86 stars, based on 1 article reviews
mu392a uc rrid ab 2923402 rabbit ant sox2 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Biogenex anti-cdx2 monoclonal antibody mu392a-uc
Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for <t>Cdx2</t> and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.
Anti Cdx2 Monoclonal Antibody Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/cdx2+antibody/pmc12274435-209-1-5
Average 90 stars, based on 1 article reviews
anti-cdx2 monoclonal antibody mu392a-uc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Biogenex mouse anti-cdx2 mu392a-uc
Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for <t>Cdx2</t> and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.
Mouse Anti Cdx2 Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/cdx2+antibody/bio_rxiv__2025__07__07__663418-152-4-6
Average 90 stars, based on 1 article reviews
mouse anti-cdx2 mu392a-uc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Biogenex mouse anti- cdx2 mu392a- uc
Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for <t>Cdx2</t> and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.
Mouse Anti Cdx2 Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/cdx2+antibody/pm40495623-65-17-20
Average 90 stars, based on 1 article reviews
mouse anti- cdx2 mu392a- uc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Biogenex mouse anti-cdx2 #mu392a-uc
Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for <t>Cdx2</t> and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.
Mouse Anti Cdx2 #Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/cdx2+antibody/pmc12130289-23-0-3
Average 90 stars, based on 1 article reviews
mouse anti-cdx2 #mu392a-uc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Biogenex mouse monoclonal antibody mu392a-uc
Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for <t>Cdx2</t> and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.
Mouse Monoclonal Antibody Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/mu128+uc+antibody/pm39504567-241-6-10
Average 90 stars, based on 1 article reviews
mouse monoclonal antibody mu392a-uc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Biogenex primary antibodies to detect trophectoderm (cdx2, biogenex mu392a-uc, 1:100)
Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for <t>Cdx2</t> and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.
Primary Antibodies To Detect Trophectoderm (Cdx2, Biogenex Mu392a Uc, 1:100), supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/cdx2+antibody/pmc11466199-81-12-14
Average 90 stars, based on 1 article reviews
primary antibodies to detect trophectoderm (cdx2, biogenex mu392a-uc, 1:100) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Biogenex anti-cdx2 mu392a-uc
Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for <t>Cdx2</t> and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.
Anti Cdx2 Mu392a Uc, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mu392a-uc/cdx2+antibody/pm38593632-37-17-21
Average 90 stars, based on 1 article reviews
anti-cdx2 mu392a-uc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for Cdx2 and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.

Journal: Scientific Reports

Article Title: Regulation of autophagy and its role in late preimplantation during mouse embryo development

doi: 10.1038/s41598-025-11359-2

Figure Lengend Snippet: Rescue of autophagy inhibition by AA supplementation. Developmental rates ( a ) and developmental results ( b ) following culture with 10 μM CQ treatment from the 4/8-cell stages to the blastocyst stage with/without AA supplementation. Scale bars represent 20 μm. ( c ) The embryos at the morula stage, cultured with CQ and AA as shown in panel ‘a,’ were immunostained for Cdx2 and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( d ) The graph shows the numbers of DAPI-positive cells counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, CZB vs. CZB + AA + CQ p = 0.007, CZB + CQ vs. CZB + AA + CQ p = 0.0015. ( e ) The graph shows the proportion of Cdx2- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( c ). Tukey–Kramer’s HSD test, Cdx2: CZB + CQ vs. CZB + AA + CQ p = 0.0012. Nanog: CZB vs. CZ + AA + CQ p = 0.0418, CZB + AA vs. CZB + CQ p = 0.0286, CZB + CQ vs. CZB + AA + CQ p = 0.0005. ( f ) The proportion of positive/negative cells in each embryo, as shown in ( c ). The cells are classified into four types: Nanog-positive (Nanog + , green), Cdx2-positive (Cdx2 + , red), double positive for Nanog and Cdx2 (Nanog + /Cdx2 + , yellow), and double negative (Nanog-/Cdx2-, gray). Tukey–Kramer’s HSD test, Cdx2-/Nanog-: CZB vs. CZB + CQ p = 0.0034, CZB + CQ vs. CZB + AA + CQ p = 0.0045. Cdx2 + /Nanog + : CZB vs. CZB + CQ p = 0.0035. ( g ) The embryos at the morula stage, cultured with CQ and AA as shown in ( a ), were immunostained for TFAP2C and Nanog, as well as with DAPI. Scale bars represent 50 μm. ( h ) The graph shows the proportion of TFAP2C- and Nanog-positive cells per total cell number counted in the embryos, as shown in ( g ). Tukey–Kramer’s HSD test, TFAP2C: no significant differences were observed . Nanog: CZB + CQ vs. CZB + AA + CQ p = 0.0322. ( i ) Relative fluorescence intensity of Nanog (green) and TFAP2C (red) in embryos shown in ( g ). Calibration was performed using DAPI fluorescence intensity.

Article Snippet: The anti-CDX2 monoclonal antibody( 1:500; BioGenex, San Ramon, CA, USA, MU392A-UC) to detect TE cells, anti-Nanog rabbit polyclonal antibody (1:500; Abcam, Cambridge, UK, ab80892) to detect the ICM cells and anti-TFAP2C(1:500; AP-2γ antibody; Santa Cruz Biotechnology, TX, USA, sc-12762) were the primary antibodies used.

Techniques: Inhibition, Cell Culture, Fluorescence